Methotrexate (MTX)-treated (0.01, 0.1, and 1 μm, 72 h) cells presented a decreasing trend of RS intensities.
← all excerpts
The emerging applications and advancements of Raman spectroscopy in pediatric cancers.
1
—
—
Methotrexate (MTX)-treated (0.01, 0.1, and 1 μm, 72 h) cells presented a decreasing trend of RS intensities.